NCT03709420View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219

PHASE1CompletedINTERVENTIONAL

Enrollment

87

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

November 11, 2020

Study Completion Date

November 11, 2020

Conditions

Endometriosis

Interventions

DRUG

Placebo

Placebo capsule to match active drug

DRUG

FOR-6219

FOR-6219 capsule

Trial Locations (1)

Unknown

Richmond Pharmacology Ltd., London

Sponsors

Lead Sponsor

Forendo Pharma Ltd

All Listed Sponsors

collaborator

Richmond Pharmacology Limited

INDUSTRY

lead

Forendo Pharma Ltd

INDUSTRY